ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,976.97
-1.13%
US Tech 100
21,079.20
-1.25%
Dow Jones
42,197.79
-1.79%
Brent Oil
73.815
0.00%
Bitcoin
104,704.89
-1.35%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. AIM ImmunoTech Inc (AIM) Quote

AIM ImmunoTech Inc

AIM ImmunoTech Inc (AIM)

Ai Media Technologies Limited
4AIM SICAF SpA
Aimia Inc
0.0949
0.00
(0.00%)
Closed June 14 4:00PM
15 min delayed - Upgrade to Realtime
0.00
0.00
(0.00%)
After Hours: -
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.0949
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.0633 52 Week Range 0.4589
Market Cap
7.253M
Previous Close
0.0949
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
89,462
Shares Outstanding
76,423,889
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
170k
Net Profit
-17.32M

About AIM ImmunoTech Inc

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alfero... AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.aimimmuno.com
Headquarters
Wilmington, Delaware, USA
Founded
-
AIM ImmunoTech Inc is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker AIM. The last closing price for AIM ImmunoTech was $0.09. Over the last year, AIM ImmunoTech shares have traded in a share price range of $ 0.0633 to $ 0.4589.

AIM ImmunoTech currently has 76,423,889 shares outstanding. The market capitalization of AIM ImmunoTech is $7.25 million.

Ask ADVFN Intelligence (AI)

AIM Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
April 23 2025
AIM (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
April 23 2025
AIM (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
April 23 2025
AIM (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
April 07 2025
AIM (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
April 04 2025
AIM (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.09490.09490.094900CS
4000.09490.09490.094900CS
12-0.0366-27.83269961980.13150.1420.0633894620.11372788CS
26-0.118-55.42508219820.21290.2540.06335531140.15831906CS
52-0.2861-75.09186351710.3810.45890.06334500990.20390729CS
156-0.7851-89.21590909090.880.890.06332604290.33974015CS
260-2.4751-96.30739299612.574.30.06338195422.02789964CS

AIM - Frequently Asked Questions (FAQ)

What is the current AIM ImmunoTech share price?
The current share price of AIM ImmunoTech is $ 0.0949
How many AIM ImmunoTech shares are in issue?
AIM ImmunoTech has 76,423,889 shares in issue
What is the market cap of AIM ImmunoTech?
The market capitalisation of AIM ImmunoTech is USD 7.25M
What is the 1 year trading range for AIM ImmunoTech share price?
AIM ImmunoTech has traded in the range of $ 0.0633 to $ 0.4589 during the past year
What is the reporting currency for AIM ImmunoTech?
AIM ImmunoTech reports financial results in USD
What is the latest annual turnover for AIM ImmunoTech?
The latest annual turnover of AIM ImmunoTech is USD 170k
What is the latest annual profit for AIM ImmunoTech?
The latest annual profit of AIM ImmunoTech is USD -17.32M
What is the registered address of AIM ImmunoTech?
The registered address for AIM ImmunoTech is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the AIM ImmunoTech website address?
The website address for AIM ImmunoTech is www.aimimmuno.com
Which industry sector does AIM ImmunoTech operate in?
AIM ImmunoTech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HUSAHouston American Energy Corp
$ 15.5499
(117.79%)
28.85M
GLLProShares UltraShort Gold
$ 20.6494
(94.81%)
1.16M
TMDETMD Energy Limited
$ 1.27
(69.85%)
85.11M
INDOIndonesia Energy Corporation Limited
$ 5.16
(45.76%)
38.52M
MXCMexco Energy Corp
$ 12.225
(44.16%)
444.35k
UGLProShares Ultra Gold
$ 37.4595
(-74.36%)
1.61M
ARCXTradr 2X Long ACHR Daily ETF
$ 18.93
(-29.86%)
509.2k
KNWKnow Labs Inc
$ 3.375
(-23.81%)
3.46M
SOARVolato Group Inc
$ 1.65
(-23.61%)
1.37M
VTAKCatheter Precision Inc
$ 0.349099
(-18.81%)
6.53M
DNNDenison Mines Corp
$ 1.635
(0.93%)
236.62M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 20.04
(-7.61%)
166.99M
EONREON Resources Inc
$ 0.5755
(19.65%)
166.35M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 1.64
(-3.24%)
154.68M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 10.17
(7.62%)
139.38M

Discussion

View Full Feed
HenryB3 HenryB3 5 minutes ago
RED FLAGS!!! Here's to your buyout, all your questions answered!
https://www.reddit.com/r/wallstreetbets/comments/1l7a5hj/my_1_million_investment_triple_up_is_about_to/
ELTP
Risk vs Reward Risk vs Reward 6 minutes ago
I have no problem buying 3's or 4's as well 🤩Could be stupidly cheap at those prices 
GTCH
midnighttoker midnighttoker 8 minutes ago
AAGC will be advancing to the new OTCID on July 01 2025.
AAGC
crazy horse 0 crazy horse 0 9 minutes ago
💥they both recently voted along with republicans to take benefits away from illegals 💥

MINNESOTA LAWMAKERS TARGETED IN MIDNIGHT SHOOTING SPREE BY FAKE COP🚨

Democratic House Speaker Emerita Melissa Hortman and her husband, Mark, were shot and kill
BullNBear52 BullNBear52 10 minutes ago
Minnesota lawmaker Melissa Hortman killed, State Sen. John Hoffman wounded in 'targeted political violence'
JON HAWORTH and EMILY SHAPIRO
Sat, June 14, 2025 at 11:57 AM EDT4 min read
https://www.yahoo.com/news/2-minnesota-lawmakers-shot-targeted-132246874.html

Jus
MasterBlastr MasterBlastr 10 minutes ago
I had to look back at garbage sports, brought me to the original 1973 Superstars which I do remember. There was supposed to be a golfer in the competition, but Arnold Palmer was already too old, and Jack Nicklaus declined to participate as he did not believe he would do well. Gary Player was ready
Monksdream Monksdream 10 minutes ago
MAXN reports Wednesday 6/18
https://investorshub.advfn.com/uimage/uploads/2025/6/14/idmbtIMG_7439.gif
MAXN
Zorax Zorax 11 minutes ago
Want to bet he will be up on a huge platform higher than anyone else? I have not seen any info about the parade until your post.
He'll be on a special chair like no one else's. Maybe behind glass too.
jman4956 jman4956 12 minutes ago
Doc,I was thinking they had a contract with Cognate and LP would have had that transfer with the sale. Is that a possibility?
NWBO
$2.00 or no deal $2.00 or no deal 13 minutes ago
LMAO...😂

Things that need to be addressed during the call:

Buyout
ELTP
JDerb JDerb 14 minutes ago
v-WAVE 3.0*

Suggested Starting Cash Value For New AIM Accounts/Positions

Individual Stocks
High Risk: At or above 51%
Neutral: Between 37 and 50%
Low Risk: At or below 36%

Diversified Funds
High Risk: At or above 34%
King_Chizzo King_Chizzo 14 minutes ago
🚨🚨🚨TIK TOK 🚨🚨🚨
🚨🚨🚨⏳⏳⏳🚨🚨🚨
🚨🚨🚨🖕🖕🖕🚨🚨🚨
🚨🚨🚨🩳🩳🩳🚨🚨
RNVA
z-money z-money 15 minutes ago
We are in a very good position here.
With news of any significant revenue stream starting up, and pps will just skyrocket, especially if our market cap is at 4M and our sh equity is 24M.
So exciting to see GIFX finally coming of age.
GIFX
$7.00 or Nothing $7.00 or Nothing 16 minutes ago
Forgot some
Things that need to be addressed during the call

Buyout
API breaks
Warrants exercise
Nasdaq
Pipeline
Revenue trend
Reimbursement of debts
Mikah partnership
Dexcel launch
New partnerships
R&d in In
ELTP
hotmeat hotmeat 16 minutes ago
The Complain-Ticons on here are hilarious, and perplexing.......nothing but whingeing and snide commentary ad nauseam.

One would think if owning Vivos was that bothersome they would do themselves the simple service of liquidating their positions and carrying on with their respective
RDGL
al44 al44 16 minutes ago
Police: ‘No Kings’ Flyers and Manifesto Found in Car of Alleged Minnesota Lawmakers Shooter

by Kristinn Taylor Jun. 14, 2025 11:23 am


The alleged gunman in the deadly shooting targeting two Minnesota Democratic–Farmer–Labor Party lawmakers and their spouses had
misterfishman misterfishman 17 minutes ago
I think he went to bed now bro. It's very early morning over there unless he doesn't sleep.lol
DTREF
Doc logic Doc logic 17 minutes ago
eagle8,

We see no evidence of a manufacturing agreement yet for US based patients. That needs to be in place so I wouldn’t get hopes up for a secret BLA submission quite yet; ). Best wishes.
NWBO
Motor-goater Motor-goater 18 minutes ago
Fortunately… we can read the 8ks therefore we’ve got the answers we need. But… by all means keep posting snippets of information that only support your false narrative. Don’t give me credit for your misinformation… FYI we are at .0030 therefore if limes bid got hit at .0005 he would be up not down.
CNNA
PayMEmf PayMEmf 19 minutes ago
An 8k was issued nearing the end of may regarding developments in Asian markets.
LQMT
Monksdream Monksdream 19 minutes ago
REE! One month
https://investorshub.advfn.com/uimage/uploads/2025/6/14/isfmnIMG_7437.gif
somberfox somberfox 20 minutes ago
Need G.B in general for anything to really matter. Nobody really knows how close it is to being done though.

Really need the GB this coming week/next to be honest.
CLNV
z-money z-money 21 minutes ago
We're slowly heading back up to 004s.
Just like where we were at when news hit that NGMC will be acquired by a defense contractor, back in January.
Soon we'll have updates, I would think.
NGMC

Your Recent History

AMEX
AIM
AIM ImmunoTech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads